Magdalena Balcerek

Dr. Magdalena Balcerek

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
ABAnja Borgmann-Staudt
Anja Borgmann-Staudt
SMSimon Michael
Simon Michael
GSGreta Sommerhaeuser
Greta Sommerhaeuser
MFMarta-Julia Fernández-González
Marta-Julia Fernández-González
LFLucía Alacán Friedrich
Lucía Alacán Friedrich
MBMagdalena Balcerek
Magdalena Balcerek
CCS often wish to have biological children yet harbour concerns about fertility impairment, pregnancy risks and the general health risks of prospective offspring. To clarify these concerns, health outcomes in survivor offspring born following ART (n = 74, 4.5%) or after spontaneous conception (n = 1585) were assessed in our European offspring study by descriptive and bivariate analysis. Outcomes were compared to a sibling offspring cohort (n = 387) in a 4:1 matched-pair analysis (n = 1681). (i) Survivors were more likely to employ ART than their siblings (4.5% vs. 3.7%, p = 0.501). Successful pregnancies were achieved after a median of one cycle with, most commonly, intracytoplasmic sperm injection (ICSI) using non-cryopreserved oocytes/sperm. (ii) Multiple-sibling births (p < 0.001, 29.7% vs. 2.5%), low birth weight (p < 0.001; OR = 3.035, 95%-CI = 1.615–5.706), and preterm birth (p < 0.001; OR = 2.499, 95%-CI = 1.401–4.459) occurred significantly more often in survivor offspring following ART utilisation than in spontaneously conceived children. ART did not increase the prevalence of childhood cancer, congenital malformations or heart defects. (iii) These outcomes had similar prevalences in the sibling population. In our explorative study, we could not detect an influence on health outcomes when known confounders, such as multiple births, were taken into account.

24 November 2015 in Klinische Padiatrie
Verified
Journal Article
Closed access
PDF file
MBMagdalena Balcerek
Magdalena Balcerek
RSR. Schilling
R. Schilling
RSR. Schlack
R. Schlack
ABA. Borgmann-Staudt
A. Borgmann-Staudt
Background: Increased risk for infertility from cancer treatment and fear of health impairment in their offspring may prevent survivors of childhood cancer from having own children. Even though most studies report no increased risk for malformations, in our German fertility study 2008 a higher occurrence of cleft lip and palate was found in offspring of former patients. Methods: Since 2010 we assess offspring’s health in a survey-based multicenter study, comparing diseases, well-being, healthcare utilization and health-related behavior between offspring from survivors, siblings or the general population. Within a first nationwide survey wave survivors who were known to have at least one child by previous fertility studies, received a questionnaire supported by the German Childhood Cancer Registry. Questionnaires were based on the KiGGS study on children’s health in the German general population conducted by the Robert-Koch Institute (n=17,641). Results: Questionnaires on 418 children were answered by 65% (254/393) of survivors contacted to participate in the first nationwide offspring study wave. Participants were more likely to be female (p<0.01), to have achieved higher educational levels (p<0.05) and to be a survivor of a soft tissue tumor (p<0.05). Former patients expressed moderate to high anxiety for the occurrence of cancer in 74% and feared other diseases in their children in 20%. Conclusion: Offspring health is a topic of major relevance to former patients. Our offspring study is currently being extended to ~ 1 500 offspring of childhood cancer survivors in Europe. Hintergrund: Ein erhöhtes Infertilitätsrisiko durch die Therapie und Angst vor gesundheitlichen Schäden der Nachkommen können ehemalige kinderonkologische Patienten daran hindern, den eigenen Kinderwunsch zu erfüllen. Obwohl die meisten Studien kein erhöhtes Fehlbildungsrisiko zeigten, zeigte sich in unserer deutschen Fertilitätsstudie 2008 ein gehäuftes Auftreten von Nachkommen ehemaliger Patienten mit Lippen-Kiefer-Gaumen-Spalte. Methoden: Seit 2010 untersuchen wir Gesundheitsfragen zu Nachkommen ehemaliger Patienten, wobei Krankheiten, Wohlbefinden, Inanspruchnahme von Gesundheitsleistungen und Gesundheitsverhalten zwischen den Nachkommen ehemaliger Patienten, der Geschwister sowie der Allgemeinbevölkerung miteinander verglichen werden. Im Rahmen der ersten bundesweiten Erhebungswelle erhielten ehemalige Patienten, von denen aus früheren Fertilitätsstudien bekannt war, ein eigenes Kind zu haben, einen Fragebogen zur Gesundheit ihrer Nachkommen über das Deutsche Kinderkrebsregister. Die Fragebögen wurden an die KIGGS Studie des Robert-Koch-Instituts zur Kindergesundheit in der deutschen Allgemeinbevölkerung (n=17 641) angelehnt. Ergebnisse: In der ersten bundesweiten Nachkommenwelle wurden Fragebögen für 418 Kinder von 65% (254/393) der angeschriebenen ehemaligen Patienten ausgefüllt. Teilnehmer waren häufiger weiblich (p<0,01), erreichten höhere Schulabschlüsse (p<0,05) und hatten häufiger die Diagnose eines Weichteiltumors (p<0,05). Ehemalige Patienten gaben in 74% eine mäßige bis hohe Angst für das Auftreten von Krebs und in 20% die Angst für andere Erkrankungen ihrer Kinder an. Schlussfolgerungen: Die Gesundheit der Nachkommen ist ein Thema von großer Bedeutung für ehemalige kinderonkologische Patienten. Unsere Nachkommenstudie wird aktuell auf ein Kollektiv von etwa 1 500 Nachkommen in Europa ausgeweitet.

18 July 2023 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Open access
PDF file
MSMadelaine Sleimann
Madelaine Sleimann
MBMagdalena Balcerek
Magdalena Balcerek
CCChirine Cytera
Chirine Cytera
FRFranziska Richter
Franziska Richter
ABAnja Borgmann-Staudt
Anja Borgmann-Staudt
JGJudith Gebauer
Judith Gebauer
Purpose Childhood cancer survivors (CCS) are at risk for increased morbidity and reduced quality of life associated with treatment-related late effects. In Germany, however, only a few of the more than 40,000 CCS registered in the German Childhood Cancer Registry (GCCR) currently benefit from adequate clinical long-term follow-up (LTFU) structures. To establish a comprehensive knowledge base on CCS’ long-term health in Germany, a database was developed in cooperation with the GCCR. Following a first evaluation phase at two German university centres, this database will be implemented more widely within Germany allowing longitudinal documentation of clinical LTFU data. Methods The feasibility study cohort comprised 208 CCS aged 18 or older whose medical, mental and psychosocial health data were collected during routine LTFU or first clinic visits in adult care. CCS were enrolled from 04/2021 to 12/2022, and data entry was completed by 03/2023. Descriptive data analysis was conducted. All CCS were stratified into three risk groups (RG) based on their individual risk for developing late effects resulting from their respective diagnoses and treatments. Results Chronic health conditions of various organ systems associated with late and long-term effects of cancer therapy affected CCS in all RG supporting the clinical relevance of risk-adapted LTFU. Enrolment into the database was feasible and broadly accepted amongst CCS. Conclusion Implementation of a clinical follow-up care infrastructure and database in Germany will pave the way to collect clinically evaluated and regularly updated health data of potentially over 40,000 German CCS and facilitate future national and international cooperation.

29 May 2024 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
MFMarta J. Fernández-González
Marta J. Fernández-González
ABAnja Borgmann-Staudt
Anja Borgmann-Staudt
CLClara González Llagostera
Clara González Llagostera
ECElena Ceballos-Garcia
Elena Ceballos-Garcia
JGJudith Gebauer
Judith Gebauer
MBMagdalena Balcerek
Magdalena Balcerek
Purpose: This study assesses fertility treatment outcomes in female patients who had undergone successful oocyte retrieval following cancer therapy. Methods: Between January 2020 and December 2022, we collected fertility treatment data from six participating centres in Spain and Germany. All patients associated with this data had undergone successful oocyte retrieval following cancer treatment. Results: Women had most frequently been diagnosed with a haematological (41.9%), breast (22.6%) or gynaecological malignancy (12.9%); two thirds (67.7%) had previously received a chemotherapy, half a radiotherapy (53.3%) and 45.2% had undergone surgery. On average, 7 years (range 0–28) had passed between cancer treatment and first ovarian stimulation cycle. Forty-nine ovarian stimulation cycles had been conducted on these 31 women between 2004 and 2021 (mean age at first oocyte collection following treatment: 34.8 ± 5.7 years). On average, 7 oocytes were collected per cycle (range 0–26) and 11 were collected per patient (range 0–51). Out of the 190 oocytes collected for immediate use of artificial reproductive technique, 139 were fertilised at a rate of 73%. Live birth rate per fresh transfer was 45% (9/20); no births were reported following cryotransfer (0/10). Mean values of anti-Mullerian hormone (AMH) before stimulation declined with time since treatment; however, oocytes were successfully collected from four women with an AMH of <0.5 ng/ml, although no pregnancies were reported. Ten pregnancies were documented; 3 ended in miscarriage. Two twin and 5 single pregnancies resulted in nine live births. On average, children were carried to term. Conclusion: In this small cohort, oocytes were successfully collected after chemotherapy and radiotherapy, despite—in individual cases—low AMH values. Further studies are needed to enrich the database and ultimately provide appropriate counselling to female cancer patients regarding expectations and ART outcome following cancer therapy.

1 December 2021 in Cancer Epidemiology
Verified
Journal Article
Closed access
GSGreta Sommerhäuser
Greta Sommerhäuser
ABAnja Borgmann-Staudt
Anja Borgmann-Staudt
RSRalph Schilling
Ralph Schilling
EFEva Frey
Eva Frey
JHJiri Hak
Jiri Hak
MBMagdalena Balcerek
Magdalena Balcerek

11 January 2024 in Frontiers in Psychology
Verified
Journal Article
Open access
NDNina Dalkner
Nina Dalkner
EFEva Fleischmann
Eva Fleischmann
ABAnja Borgmann-Staudt
Anja Borgmann-Staudt
CFChristine Fürschuß
Christine Fürschuß
SKStephanie Klco-Brosius
Stephanie Klco-Brosius
MBMagdalena Balcerek
Magdalena Balcerek
Current literature reveals no increased risk for adverse non-hereditary health outcomes in the offspring of childhood cancer survivors (CCS), yet survivors reported concerns regarding their offspring’s health. To investigate how the fear of cancer development in offspring influences parental behavior related to health and prevention, survey reports from 256 European adult CCS and 256 age- and sex-matched siblings who participated in a multicenter study on offspring health were analyzed in the present study. Analyses of covariance and chi-square tests were conducted to test for differences between CCS and siblings in outcome variables (all related to healthy parenting behavior). CCS reported higher fear levels (p = 0.044, Partial η2 = 0.01) and less alcohol consumption (p = 0.011, Phi = 0.12) and smoking (p = 0.022, Phi = 0.11) during pregnancy than siblings. In survivor families, children were breastfed less often (p < 0.001, Phi = 0.18). Partial correlation analyses showed that CCS’ fear levels decreased with increasing age (r = −0.16, p = 0.014), time since oncological therapy (r = −0.19, p = 0.003), and number of children (r = −0.21, p = 0.001). Overall, due to their own experiences with cancer, many CCS harbor misperceptions regarding the health outcomes of their offspring. Although the fear decreases with increasing distance from the active disease, any fear should be taken seriously, even if unfounded, and combated through targeted educational measures.